Home > News > Intel charts new seas
November 21st, 2003
Intel charts new seas
For the first time, Intel Corp. has made available its chip-making nanotechnology tools to cancer researchers in the hope that being able to detect tiny defects in silicon chips also will work in human tissue to diagnose and study cancer. Though just preliminary research, Intel's union with the Fred Hutchinson Cancer Research Center in Seattle is part of a voyage toward its future beyond pure-silicon manufacturing. After all, Intel's advanced chips will be commodities within several years, say experts.
Low-power tunneling transistor for high-performance devices at low voltage December 12th, 2013
Chicago Awareness Organization First Not-for-Profit to Sponsor Dog Training to Detect Ovarian Cancer Odorants December 12th, 2013
Iranian Scientists Discover New Electrical Device for Rapid Diagnosis of Cancer December 12th, 2013
Arrowhead to Report Fiscal 2013 Fourth Quarter and Year-End Financial Results - Conference Call Scheduled for Wednesday, December 18, 2013 December 12th, 2013